A unified electrocatalytic description of the action of inhibitors of nickel carbon monoxide dehydrogenase.
Several small molecules and ions, notably carbon monoxide, cyanide, cyanate, and hydrogen sulfide, are potent inhibitors of Ni-containing carbon monoxide dehydrogenases (Ni-CODH) that catalyze very rapid, efficient redox interconversions of CO(2) and CO. Protein film electrochemistry, which probes the dependence of steady-state catalytic rate over a wide potential range, reveals how these inhibitors target particular oxidation levels of Ni-CODH relating to intermediates (C(ox), C(red1), and C(red2)) that have been established for the active site. The following properties are thus established: (1) CO suppresses CO(2) reduction (CO is a product inhibitor), but its binding affinity decreases as the potential becomes more negative. (2) Cyanide totally inhibits CO oxidation, but its effect on CO(2) reduction is limited to a narrow potential region (between -0.5 and -0.6 V), below which CO(2) reduction activity is restored. (3) Cyanate is a strong inhibitor of CO(2) reduction but inhibits CO oxidation only within a narrow potential range just above the CO(2)/CO thermodynamic potential--EPR spectra confirm that cyanate binds selectively to C(red2). (4) Hydrogen sulfide (H(2)S/HS(-)) inhibits CO oxidation but not CO(2) reduction--the complex on/off characteristics are consistent with it binding at the same oxidation level as C(ox) and forming a modified version of this inactive state rather than reacting directly with C(red1). The results provide a new perspective on the properties of different catalytic intermediates of Ni-CODH--uniting and clarifying many previous investigations.
Inorganic Chemistry Laboratory, Department of Chemistry, University of Oxford, South Park Road, Oxford OX1 3QR, UK.
Vincent C-C
VC
Wang
Mehmet
M
Can
Elizabeth
E
Pierce
Stephen W
SW
Ragsdale
Fraser A
FA
Armstrong
D000445:Aldehyde Oxidoreductases / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D055162:Biocatalysis; D002245:Carbon Dioxide / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D002248:Carbon Monoxide / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000494:pharmacology*; D020134:Catalytic Domain / Q000187:drug effects; D003486:Cyanides / Q000494:pharmacology; D055664:Electrochemical Techniques; D006862:Hydrogen Sulfide / Q000494:pharmacology; D008958:Models, Molecular; D009097:Multienzyme Complexes / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D010084:Oxidation-Reduction; D013329:Structure-Activity Relationship
D003486:Cyanides; D009097:Multienzyme Complexes; D002245:Carbon Dioxide; D002248:Carbon Monoxide; D000445:Aldehyde Oxidoreductases; C019823:carbon monoxide dehydrogenase; D006862:Hydrogen Sulfide